The Impact of ADHD and Perimenopause in Professional Women: What Employers and Physicians Should Know

For most women, perimenopause is presented as a predictable life stage beginning sometime in the mid-40s. But for women with ADHD, that timeline may be off by a decade, and the severity of what they experience may be twice as intense.

‍

A landmark 2025 population-based cohort study published in European Psychiatry followed 5,392 women aged 35–55, and found that women with ADHD experienced the peak of perimenopausal symptoms between ages 35 and 39 — compared to ages 45 to 49 among women without ADHD. That is not a minor statistical difference: it's a entirely different life stage. And yet most of these women are sitting in primary care offices, HR meetings, or performance reviews with no one connecting the dots.

‍

Let's take a look into the science to finally make sense of it.

‍

‍

Gliss Wellness provides expert-based, affordable menopause care through our nationwide telehealth platform. Book a free 15-minute appointment at findgliss.com.

‍

‍

The Biology: Why ADHD and Hormones Are Deeply Entangled

‍

ADHD is, at its core, a disorder of dopamine regulation. Just like the hormonal transition of perimenopause.

‍

Estrogen works as a a neuromodulator that enhances dopamine and serotonin activity in the brain. It supports working memory, emotional regulation, focus, and executive function. When estrogen declines during perimenopause, the brain loses a key chemical scaffold that was quietly compensating for ADHD symptoms all along.

‍

For women without ADHD, this decline is challenging. But for women with ADHD, whose dopamine systems were already under-resourced, the drop can feel catastrophic. The 2025 cohort study found that women with ADHD had significantly higher total perimenopausal symptom scores than women without ADHD (18.0 vs. 13.0), with greater severity across all three categories:

‍

• Somatic symptoms: hot flashes, sleep disruption, fatigue
• Psychological symptoms: depressive mood, anxiety, cognitive fog, irritability
• Urogenital symptoms: vaginal dryness, urinary changes

‍

On top of that, an ADDitude survey of nearly 5,000 women found that 93% of respondents aged 45 and older reported elevated and worsened ADHD symptoms during perimenopause and/or menopause.

‍

The Diagnostic Gap: Women Are Still Being Missed

‍

Before we can address perimenopause in women with ADHD, we have to acknowledge a prior failure: most of these women were never properly diagnosed with ADHD in the first place.

‍

Girls with ADHD are systematically underdiagnosed. Their symptoms (often inattentive rather than hyperactive) are attributed to anxiety, depression, perfectionism, or simply "being scattered." The result: they arrive at midlife with decades of unrecognized struggle and no language for it.

‍

Research published in Frontiers in Global Women's Health (2025) notes that "a less conspicuous symptomology results in delayed diagnosis and treatment of adult ADHD, particularly in women," and that the experience of struggling through perimenopause is "often a catalyst for seeking an ADHD diagnosis." In other words: the hormonal crisis of midlife is, for many women, the moment the mask finally slips — and the first time a doctor pays attention.

‍

However, this can be easily preventable.

‍

What Physicians Need to Know and Do

‍

1. Think ADHD when a woman in her 30s or 40s presents with cognitive symptoms

‍

Brain fog, forgetfulness, emotional dysregulation, inability to focus, and sleep disruption in a woman in her late 30s or early 40s should prompt a differential that includes both perimenopause and ADHD at the same time. The 2025 study makes clear that these conditions compound each other.

‍

Screening tools like the Adult ADHD Self-Report Scale (ASRS) take under five minutes and can be administered during a routine visit. A referral for neuropsychological testing or to a psychiatrist experienced with women's ADHD is appropriate when screening is positive.

‍

2. Don't misattribute ADHD symptoms to menopause alone

‍

A woman presenting with new or worsening cognitive difficulties during perimenopause may actually have undiagnosed ADHD that has been unmasked by hormonal decline. Treating only the menopause without addressing the ADHD will leave her significantly under-treated.

‍

As the clinical literature now supports: "Clinicians may see more women presenting with ADHD as they move into perimenopause or menopause and estrogen levels decline."

‍

3. Consider HRT as part of the ADHD treatment plan

‍

The evidence for hormone replacement therapy (HRT) in women with ADHD is emerging and promising, though not yet definitive. What we know:

‍

• Estrogen supports dopamine pathways that are central to ADHD symptom management.
• Transdermal estrogen (patches, gels, sprays) is particularly effective at enhancing dopamine activity, which may directly improve focus and cognitive clarity.
• Many women with ADHD report that HRT stabilizes mood, reduces brain fog, and improves their response to ADHD medication.
• An important clinical note: progesterone can have a neuroinhibitory effect and may counteract some of estrogen's cognitive benefits: dosing and delivery matter and should be discussed with a menopause specialist.

‍

What Employers Need to Know and Do

‍

Approximately $43 billion in combined productivity and healthcare costs are attributed annually in the US to untreated or under-supported ADHD in the workforce. That figure doesn't account for the disproportionate impact on perimenopausal women, whose symptoms may be peaking precisely during the most valuable years of their career.

‍

ADHD is a protected disability under the Americans with Disabilities Act (ADA) for employers with 15 or more employees. Reasonable accommodations are not optional once an employee discloses. However, the most forward-thinking employers are already building ADHD-inclusive workplaces by default.

‍

Reduce Distractions at the Environmental Level

‍

Research consistently shows that it takes an average of 23 minutes and 15 seconds to fully regain focus after an interruption. For an employee with ADHD, that recovery cost is even steeper. Employers can reduce this burden by:

‍

• Offering quiet zones or focus rooms free from ambient conversation
• Allowing remote or hybrid work for roles where physical presence is not required (flexibility dramatically reduces sensory and social load)
• Adopting asynchronous communication norms: reducing mandatory real-time meetings minimizes the constant task-switching that fragments attention
• Providing noise-canceling headphones as standard office equipment
• Minimizing open-plan office noise through acoustic panels, private pods, or flexible seating

‍

Provide Structural and Managerial Support

‍

Research on ADHD in the workplace identifies the following managerial behaviors as particularly effective:

‍

• Clear delegation: define exactly what is expected, by when, and in what format.
• Explicit deadlines with milestone check-ins: interim accountability replaces anxiety-based procrastination
• Written follow-up after verbal instructions: removes the burden of working memory
• Flexible scheduling: allowing employees to work during their peak cognitive hours (often not 9am) improves output quality significantly

‍

Offer or Subsidize ADHD Coaching

‍

Providing access to a certified ADHD or executive function coach is recognized by the Job Accommodation Network (JAN) as an evidence-based accommodation. This can be offered through:

‍

• Employee Assistance Programs (EAPs): many already cover coaching and can be expanded to include ADHD-specialized coaches
• Professional development budgets: reframing coaching as a professional skill investment rather than a medical accommodation reduces stigma
• External referrals :organizations like the ADHD Coaches Organization (ACO) and coaches certified through the International Coaching Federation (ICF) with ADHD specializations maintain directories

‍

Research on neurodivergent workers consistently links these accommodations to better job retention, higher job satisfaction, and measurable productivity gains.

Create Psychological Safety Around Disclosure

‍

Many women with ADHD do not disclose to employers because they fear being perceived as incompetent or unreliable. This silence is costly, both for them and for the organization. Employers can reduce the disclosure barrier by:

‍

• Including ADHD and neurodivergence explicitly in DEI and employee wellness communications
• Training managers to respond to disclosure with curiosity and problem-solving rather than performance management
• Normalizing the use of accommodations across the entire workforce (many strategies like clear deadlines and quiet workspaces can actually benefit everyone)

‍

When Perimenopause Meets the Workplace

‍

For a woman with ADHD entering perimenopause in her late 30s or early 40s, the compounding is significant. She may be:

‍

• Experiencing cognitive fog severe enough to affect her writing, recall, and decision-making
• Sleeping poorly due to night sweats or anxiety
• Managing emotional dysregulation that she's always had but that is now harder to mask
• Dealing with a body that feels unfamiliar while trying to sustain a demanding career

‍

And she is likely doing all of this without a diagnosis, without a provider who has connected the dots, and without a workplace that understands what she needs.

‍

Here's the good news: all the support strategies listed in this article are available, with no need of new technology or drugs. It's all about raising awareness, facilitating communication and willingness to create the right environment for women with ADHD and/or perimenopause — and all employees equally.

‍

Gliss Wellness provides expert-based, affordable menopause care through our nationwide telehealth platform. Book a free 15-minute appointment at findgliss.com.

‍